Clinical Trial Update: Multiple Ascending Dose Study of SPC4955 in Healthy Subjects [Phase 1]

View source ↗

Summary

The document reports the completion of a Phase 1 multiple ascending dose study of SPC4955 in healthy subjects for hypercholesterolemia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypercholesterolemia

Drugs mentioned

• SPC4955

Snippet

Sponsor: Santaris Pharma A/S | Conditions: Hypercholesterolemia | Phase 1 | Status: COMPLETED